P2‐306: Activation of both LXRα and LXRβ is required for TO901317‐mediated lowering of Aβ42: implications for the development of Alzheimer's therapeutics
David Riddell(Eli Lilly (United States)), Peter H. Reinhart(University of Massachusetts Amherst), Z. Li(Princeton University), Hua Zhou(Dalian Medical University), Knut R. Steffensen(Karolinska Institutet), Evguenia Kouranova(Princeton University), Robert H. Ring(Autism Speaks), Steve Jacobsen, Jan-Ακε Gustafsson(University of Houston), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Suzan Aschmies(Princeton University), H.W. Warwick(Princeton University)
Cited by 0
Related Papers
Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation
|Cell|1988|598
Whole-genome sequencing of quartet families with autism spectrum disorder
|Nature Medicine|2015|540
Proteogenomic Characterization of Endometrial Carcinoma
|Cell|2020|534